Clark Wealth Partners’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.55K Buy
23
+4
+21% +$266 ﹤0.01% 445
2026
Q1
$1.19K Buy
+19
New +$1.32K ﹤0.01% 501
2025
Q2
Sell
-26
Closed -$1.78K 564
2025
Q1
$1.78K Hold
26
﹤0.01% 389
2024
Q4
$2.02K Buy
+26
New +$1.93K ﹤0.01% 357

Other funds holding DXCM

Clark Wealth Partners's DXCM Position: Q2 2026 in Review

Clark Wealth Partners increased its DexCom (DXCM) stake by 21% in Q2 2026, buying an estimated $266 and bringing the position to 23 shares worth $1.55K. The position accounts for ﹤0.01% of the portfolio, ranked #445.

Clark Wealth Partners first reported a position in DXCM in Q4 2024 and has held it in 4 quarters since. The position peaked at $2.02K in Q4 2024. 919 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Clark Wealth Partners held 23 shares of DexCom worth $1.55K as of Q2 2026.
  • Clark Wealth Partners bought 4 DexCom shares in Q2 2026, an estimated $266.
  • DexCom made up ﹤0.01% of Clark Wealth Partners's portfolio in Q2 2026, its #445 holding.
  • Clark Wealth Partners first reported a position in DexCom in Q4 2024 and has held it in 4 quarters since.
  • Clark Wealth Partners's DexCom position peaked at $2.02K in Q4 2024.
  • 919 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Clark Wealth Partners's 13F filing for Q2 2026, filed 28 Jul 2026.